Promising research offers hope in the fight against resistant bacteria

FHS
October 3, 2024
12:16 pm

Antibiotic resistant bacteria threaten global health. Nevertheless, few new antibiotics have come onto the market in the last 50 years.

J&J takes 340B fight with federal government to court

Johnson & Johnson is suing the federal government over its rebuke of the company’s alternative model for 340B drug price discounts. The company asked a

November 14, 2024

Scale Biosciences announces ScalePlex technology to simplify single cell genomics studies of any scale

Novel multiplexing technology enables seamless sample pooling facilitating cost-efficient single cell experiments for compound screening and translational research.

June 26, 2024

Mainz Biomed Provides Year-End Corporate Review 2023 – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 09.01.2024 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

January 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.